Kimia Biosciences Appoints Naveen Sharma as CFO After Leadership Change
Kimia Biosciences Limited has successfully transitioned its financial leadership with the appointment of Mr. Naveen Sharma as Chief Financial Officer on January 7, 2026, immediately following the resignation of former CFO Pradip Kumar Sharma. The new CFO brings over 18 years of chartered accountancy experience across financial services, manufacturing, and banking sectors, with expertise in digital transformation and regulatory compliance.
*this image is generated using AI for illustrative purposes only.
Kimia Biosciences Limited has announced the appointment of Mr. Naveen Sharma as Chief Financial Officer, effective January 7, 2026. This appointment follows the recent resignation of former CFO Mr. Pradip Kumar Sharma, who stepped down on January 6, 2026, citing personal reasons. The pharmaceutical company informed BSE Limited about both key managerial personnel changes under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Leadership Transition Details
The Board of Directors approved Mr. Naveen Sharma's appointment during their meeting held on January 7, 2026, which commenced at 14:30 PM and concluded at 15:00 PM. This swift appointment demonstrates the company's commitment to maintaining continuity in its financial leadership. The transition occurred just one day after the previous CFO's departure, ensuring minimal disruption to the company's operations.
| Position Changes: | Details |
|---|---|
| Outgoing CFO: | Mr. Pradip Kumar Sharma |
| Resignation Date: | January 6, 2026 |
| New CFO: | Mr. Naveen Sharma |
| Appointment Date: | January 7, 2026 |
| Board Meeting Duration: | 14:30 PM - 15:00 PM |
New CFO Profile and Experience
Mr. Naveen Sharma brings extensive expertise to his new role as a Chartered Accountant with over 18 years of experience in finance, accounting, governance, and strategic leadership. His professional background spans across multiple sectors including financial services, EPC, manufacturing, and banking. He possesses comprehensive expertise in financial controlling, business planning, commercial finance, ERP implementation, digital transformation, governance, and regulatory compliance.
| Professional Background: | Details |
|---|---|
| Qualification: | Chartered Accountant |
| Total Experience: | 18+ years |
| Sector Expertise: | Financial services, EPC, manufacturing, banking |
| Key Skills: | Financial controlling, business planning, ERP implementation |
| Specialization: | Digital transformation, governance, regulatory compliance |
Regulatory Compliance and Documentation
The company has fulfilled its obligations under SEBI regulations by submitting the required documentation to BSE Limited for both the resignation and appointment. Company Secretary and Compliance Officer Pallavi Garg (Membership No.: A69848) signed the official intimation documents on January 7, 2026. The filing includes all details mandated under SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024.
Company Information
Kimia Biosciences Limited operates in the pharmaceutical sector with its registered office and works located at Village Bhondsi, Damdama Lake Road, Gurugram, Haryana. The company maintains its corporate office at Aggarwal Millennium Tower-II, Netaji Subhash Place, Pitampura, New Delhi. The company trades on BSE under scrip code 530313 with the symbol KIMIABL. Additional information regarding these appointments is available on the company's website at www.kimiabiosciences.com .
Historical Stock Returns for Kimia Biosciences
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.80% | -6.92% | +8.97% | -54.09% | -28.84% | -47.33% |
20
